23rd June 2020, Frederick, Maryland, — Kemp Proteins, a leading provider of gene-to-protein and monoclonal antibody development services, today announced that the company has received ISO9001:2015 certification for the development and manufacturing of protein-based products and services to the pharmaceutical, diagnostics, and research industries. The decision to pursue ISO9001 accreditation demonstrates Kemp’s commitment to a culture of continuous improvement focused on providing clients with world-class protein development services.
Michael Keefe, CEO of Kemp Proteins commented, “In the last 18 months, we have increased facility space from 3,000 to 12,000 square feet, personnel from 5 to 22, obtained AAALAC accreditation for our vivarium and now achieved ISO9001 certification. We are positioning ourselves as a world-class bioservices company, one that attracts high achieving and driven personnel. All of these advancements are a testament to the hard work of the team and the high level of quality we expect throughout the development, manufacturing and support of our clients. These milestones provide a solid quality base for our company – one that we will build upon. We are committed to becoming ISO13485 within the near future.”